129742939250781250_118Dean diagnosis: 300,244 business development and investment in research and development go hand in hand Dean diagnosis medical and biological research agencies: Orient securities analyst: Zhuang Yan, Li Shuhua writing date: 2012-02-20 event: company announcements: 1. Zhejiang Yangtze Delta region Institute of Tsinghua University, and the Institute of biotechnology and pharmaceutical cooperation plan, program in science and technology research and development, Transformation, laboratory construction, and cooperation, and has signed a strategic cooperation agreement, 2. China Shanghai Dean test license for access to the forensic, admissible expert testimony services. Research findings, we think, shows that companies of such a notice in both product development and business development efforts are constantly made, its affiliates obtain the qualification for forensic companies graduallyRich product line has an important role and inputs for the future promotion of Dean on the research and development of core competence has important significance. Forensic services with fast growth potential. Although forensic services low percentage, but taking into account the forensic examination of the overall market potential and its level of profitability, the business is expected to be another growth point of the company's medical diagnostics business. From the entireMarket, current forensic examination of forensic medicine as a whole class of compound growth of more than 22% over the past 5 years, forensic evidence in such detection 2010 growth; at present as the DNA detection technology matures, including forensic evidence of DNA paternity testing project is in great demand, and with the future establishment and perfection of criminal DNA database, market is expected toFurther open.
Shanghai Hangzhou after Dean, Dean was the Dean of the second access to qualifications of forensic diagnostics system within the company, is expected to increase further in the future, its corporate business layout of forensic importance. Good investment in research and development to improve ICL business core competitiveness in the future. Despite the competitiveness of ICL format before continues to focus on quality asReferences, to scale based on the cost advantages of; but when it develops to a certain stage, tracking, development and promotion of new detection technologies as well as new business creating ability would gradually become important indicators of competitiveness of ICL, and current importance to investment in research and development cooperation on the long-term development of the company has important significance. (According to the bulletin, Research Institute of biotechnology and medicine is Zhejiang Tsinghua YangtzeDelta Research Institute one of the important research platform, applied enzymology laboratory of Zhejiang Provincial key laboratories, research interests includes biomedical reference materials development, important features of enzymes in basic and applied research, development and industrialization of new enzymes and enzyme research team, for the provincial key science and technology innovation team. ) Maintain companies outperform rating. Our analysis of the ICLFit demand for healthcare reform in China, third-party diagnostic industry has a rapid development policy opportunities; Dean diagnosis is one of the pioneers of the ICL chain enterprises in China, its marketing, on both technical and management system has its own characteristics, and epitaxial growth of health both within a given the chance, are expected to benefit fully from the growth of the industry. In view of the above considerations is not apparent in the short term shadowPerformance of the company
the secret world gold, we maintain the forecast EPS of 2011-2013 of the company respectively, 0.84 and $ 1.54; we think its worth looking forward to long term Outlook, short-term valuation is relatively expensive, and maintain the holdings of the company's investment rating, it is recommended that active interest. Risk factors: increased competition, market adversely, personnel policy bottlenecks
rift plat, risks
aoc gold,Roche's cooperation. Online statement Gold: gold online reprint of the above content, does not indicate that confirm the description, for investors ' reference only and does not constitute investment advice. Investor operations accordingly, at your own risk.
沒有留言:
張貼留言